Omeros (OMER) Return on Sales [ROS] (2010 - 2026)
Omeros' Return on Sales [ROS] was 0.26% in Q2 2026, up 231.59 percentage points from -231.33% a year earlier and up 176.35 percentage points from the prior quarter.
Powered by 
Analysis
Omeros (OMER) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Omeros' Return on Sales [ROS] was -189.53% through Jun 30, 2026, up 41.80 percentage points year-over-year; for FY2020, it came in at -212.59%, down 81.97 percentage points from FY2019.
- Return on Sales [ROS] shows a five-year change of +314.75 percentage points (FY2015 to FY2020).
- In earlier years, Return on Sales [ROS] was -130.62% in FY2019 (+245.11 pp), -375.73% in FY2018 (-308.01 pp), -67.72% in FY2017 (+62.70 pp) and -130.42% in FY2016 (+396.92 pp).
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] in data going back to Q2 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Omeros | 1.34 Bn | 1.34 Bn | 27.73 Mn | 0.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26% |
| Mar 31, 2026 | -176.09% |
| Jun 30, 2025 | -231.33% |
| Mar 31, 2025 | -203.90% |
| Sep 30, 2021 | -132.74% |
| Jun 30, 2021 | -158.24% |
| Mar 31, 2021 | -215.04% |
| Dec 31, 2020 | -318.06% |
| Sep 30, 2020 | -97.37% |
| Jun 30, 2020 | -204.58% |
| Mar 31, 2020 | -100.59% |
| Dec 31, 2019 | -70.93% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -34.90% |
| Mar 31, 2019 | -88.34% |
| Dec 31, 2018 | -83.91% |
| Sep 30, 2018 | -769.14% |
| Jun 30, 2018 | -1,849.97% |
| Mar 31, 2018 | -1,743.64% |
| Dec 31, 2017 | -102.62% |
API Access
Omeros Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();